Related Experiment Video
Updated: Jul 7, 2026

Characterization of a Novel Human Organotypic Retinal Culture Technique
Published on: June 9, 2021
The role of inflammatory cytokines in diabetic nephropathy
Juan F Navarro-González1, Carmen Mora-Fernández
1Servicio de Nefrología, Hospital Universitario Nuestra Señora de Candelaria, Carretera del Rosario, 145, 38010 Santa Cruz de Tenerife, Spain. jnavgon@gobiernodecanarias.org
Abstract:
Cytokines act as pleiotropic polypeptides regulating inflammatory and immune responses through actions on cells. They provide important signals in the pathophysiology of a range of diseases, including diabetes mellitus. Chronic low-grade inflammation and activation of the innate immune system are closely involved in the pathogenesis of diabetes and its microvascular complications. Inflammatory cytokines, mainly IL-1, IL-6, and IL-18, as well as TNF-alpha, are involved in the development and progression of diabetic nephropathy. In this context, cytokine genetics is of special interest to combinatorial polymorphisms among cytokine genes, their functional variations, and general susceptibility to diabetic nephropathy. Finally, the recognition of these molecules as significant pathogenic mediators in diabetic nephropathy leaves open the possibility of new potential therapeutic targets.
Insights
Chronic inflammation and specific cytokines like IL-6 are key in diabetic nephropathy development. Understanding cytokine genetics may reveal new therapeutic targets for this diabetes complication.
Area of Science:
- Immunology
- Endocrinology
- Genetics
Background:
- Cytokines are crucial polypeptides that regulate inflammatory and immune responses.
- Chronic low-grade inflammation and innate immune system activation are implicated in diabetes mellitus and its microvascular complications.
- Specific inflammatory cytokines, including Interleukin-1 (IL-1), Interleukin-6 (IL-6), Interleukin-18 (IL-18), and Tumor Necrosis Factor-alpha (TNF-alpha), play roles in diabetic nephropathy.
Purpose of the Study:
- To explore the role of inflammatory cytokines in the pathogenesis of diabetic nephropathy.
- To investigate the significance of cytokine genetics, including combinatorial polymorphisms and functional variations, in susceptibility to diabetic nephropathy.
- To identify potential therapeutic targets based on the role of cytokines in diabetic nephropathy.
Main Methods:
- Review of existing literature on cytokines, inflammation, and diabetic nephropathy.
- Analysis of the involvement of specific cytokines (IL-1, IL-6, IL-18, TNF-alpha) in disease development.
- Examination of the contribution of genetic variations in cytokine genes to diabetic nephropathy susceptibility.
Main Results:
- Inflammatory cytokines are significant mediators in the development and progression of diabetic nephropathy.
- Cytokine genetics, particularly polymorphisms, are of interest for understanding susceptibility.
- These findings highlight the link between inflammation, genetics, and diabetic kidney disease.
Conclusions:
- Inflammatory cytokines are key players in the pathophysiology of diabetic nephropathy.
- Genetic factors related to cytokines may influence an individual's susceptibility to diabetic nephropathy.
- Targeting these cytokine pathways presents a potential strategy for future therapeutic interventions in diabetic nephropathy.
Related Concept Videos
Diabetic Nephropathy
Diabetic Neuropathy
Type I Diabetes II: Pathophysiology
Inflammatory Bowel Disease III: Crohn's Disease
Diabetic Retinopathy
Type II Diabetes II: Pathophysiology